|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 550.96 USD | -2.82% |
|
-6.09% | -18.56% |
| 08-11 | IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment | MT |
| 08-11 | Idexx Laboratories Launches Catalyst Probnp Test for Cardiac Assessment in Cats and Dogs | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
IDXX 550.96 $
-2.82%
292M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| IDXX | 550.96USD | -2.82% | 292M $ | |
CBOE
| IDXX | 550.56USD | -2.89% | 8.07M $ | |
|
Mexican S.E.
| IDXX * | 10,400.00MXN | +7.77% | 5.41M $ | |
|
Tradegate
| IX1 | 476.00EUR | -3.19% | 31.89K € | |
|
London S.E.
| 0J8P | 581.90USD | +2.75% | 20.37K $ | |
|
Wiener Boerse
| IDXX | 481.10EUR | -1.64% | 10.58K € | |
|
Boerse Muenchen
| IX1 | 476.85EUR | -2.96% | 8.58K € | |
|
Xetra
| IX1 | 482.70EUR | -2.54% | 4.83K € | |
|
Deutsche Boerse AG
| IX1 | 489.50EUR | -0.67% | 0 € | |
|
Börse Stuttgart
| IX1 | 476.30EUR | -3.19% | 0 € | |
|
Berne S.E.
| IX1 | 451.80CHF | -1.40% | 0 CHF | |
|
Borsa Italiana
| 1IDXX | 480.50EUR | -1.80% | 0 € | |
Sao Paulo
| I1DX34 | 578.89BRL | -2.05% | 2.89K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 595.76 | 660.71 | 629.35 |
| Spread/Res. | -7.52% | -16.61% | -12.46% |
| Spread/Supp. | +2.15% | +4.66% | +4.19% |
| Support | 539.36 | 526.44 | 528.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IDXX Stock
- Charts IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
